The University of Chicago Header Logo

Connection

Peter H. O'Donnell to Antibodies, Neoplasm

Back to Details
This is a "connection" page, showing publications Peter H. O'Donnell has written about Antibodies, Neoplasm.
Peter H. O'Donnell
Connection Strength
0.358
Antibodies, Neoplasm
  1. Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease. Leuk Lymphoma. 2010 Dec; 51(12):2240-9.
    View in: PubMed
    Score: 0.358
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.